Board of Directors & Advisory Board

Greg Fenton is a seasoned investment professional, with a Bay Street career spanning nearly 30 years. He has worked in various capacities with ever-increasing responsibility in both the Canadian banking and investment management sectors. Greg has been a partner in three investment management firms, heading the Risk Solutions Group at Scotiabank and leading Liability Driven Investment Group at National Bank Financial. His experience spans many disciplines: capital markets, investment management, actuarial, pension, insurance, accounting, tax and risk management. He also acts as an advisory board member to numerous corporations.

Eric Wallman is a graduate of the University of Manitoba in 1983 and obtained a full CA designation in 1986. He has held senior accounting and finance positions in industry since 1991 and has been an active investor in the junior mining market since 1992. Currently, Eric is the Senior Vice-President, Finance and Administration with Bothwell Cheese, the largest independently owned cheese manufacturer in Canada. His role includes strategic planning for Bothwell Cheese and two related companies. Mr. Wallman is also an active board member of the Western Dairy Council.

Francis brings an entrepreneurial mindset to his science and healthcare background, which has been foundational to Zentek's early success. Francis has significant experience in intellectual property development and management, including the research, development, and patent granting of ZenGUARD(TM) - a graphene-silver composite used to enhance the pathogen filtration of various types of media. He also has deep knowledge and experience in the areas of strategic planning, fundraising, and capital markets.

John Snisarenko brings with him 35 years of specialty pharmaceutical, medical device and commercialization experience spanning from start-up to large pharmaceutical and biotech companies, including 15 years in the United States in executive positions with Genentech and Shire. He was also a key member of the Genentech/Novartis Global Alliance Partnership for Lucentis in ophthalmology. Currently, he serves as an Independent Director, Board Member and Advisor to numerous companies.
John holds a B.Sc. in Biochemistry and an MBA in Marketing and International Business from McGill University in Montreal, Canada.

Brian Bosse has been a respected professional investor for nearly 30 years with corporate capital allocation policy being his key business specialty. He forms and motivates great teams revolve around stakeholder return on investment using leadership styles that fuel employee intellectual curiosity. Formerly Brian served Dundee Corporation’s Goodman & Company Investment Counsel as portfolio manager of the Goodman Bluespring Fund. He earned an honors degree from the Lazaridis School of Business and Economics in Waterloo Ontario plus the Chartered Financial Analyst designation. Brian joined Zentek in May 2018 as director and officer following a successful proxy battle.

Ilse Treurnicht’s career spans scientific research and commercialization, building health and cleantech firms, venture and impact capital, and public policy. She is managing partner of TwinRiver Capital (an impact investment firm), a general partner at North South Ventures (a seed stage med fund), chair of the Public Policy Forum and a director of the Equality Fund.

Ilse was CEO of MaRS Discovery District in Toronto from 2005-2017 as it developed from a nascent organization into a leading urban innovation hub. She joined MaRS from her role as CEO of Primaxis Technology Ventures, a seed stage venture capital firm (1999-2005).

She was chair of the Canadian Task Force on Social Finance (2010), served on the Government of Canada’s Science, Technology and Innovation Council (2014-2016), Canada’s Advisory Council on Economic Growth (2016-2019), and the Advisory Committee on Open Banking (2018-2021), as well as the boards of several technology firms and non-profit organizations.

Ilse holds a doctorate in chemistry from Oxford University, which she attended as a Rhodes Scholar.

Lisa Sim is a partner with Miller Thomson LLP and member of the Executive Committee. Lisa practises intellectual property law with a focus on protecting, commercializing, and managing the intellectual assets of her clients. She is a registered patent agent in Canada and the United States, as well as a registered Canadian trademark agent.

Lisa’s practice encompasses all aspects of intellectual property law with extensive experience in obtaining patent, industrial design, and trademark protection worldwide, conducting intellectual property due diligence and technology audits, managing intellectual property disputes including assessing patent infringement and validity risks and supporting intellectual property litigation, assisting organizations to manage their intellectual property portfolios, as well as advising on licensing matters and related contractual agreements.

Lisa provides legal services to clients that include small-to-medium enterprises (SME), universities, research institutions, and sole inventors. Lisa is committed to providing business-focused and cost-effective solutions that align with her clients’ business objectives. She has been recognized by her peers in legal directories such as The Best Lawyers in Canada.

Prior to pursuing a career in law, Lisa completed graduate work in microbiology. She then worked for several years as IP counsel at other leading intellectual property law firms before joining Miller Thomson.